Cholesterol emboli syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
__NOTOC__
'''For patient information click [[Cholesterol emboli syndrome (patient information)|here]]'''
{{CMG}}; {{AE}} {{NN}}<br>
==Overview==
[[Cholesterol emboli]] was first described by a Danish pathophysiologist called Peter Ludvig Panum in 1862. The first case series of [[Arterial Occlusions]] due to [[Emboli]] were reported from 267 autopsies in the New York Hospital by Curtis M. Flory in 1945. The [[cholesterol]] crystals were first identified by polarized light in 1956. [[atheromatous]] [[embolization]] following [[vascular]] surgery was first diagnosed by Thurlbeck and Castleman in 1957. The [[cholesterol emboli]] in the [[retinal]] [[arterioles]] was first described by an ophthalmologist called Dr Robert Hollenhorst in 1961, which is known as Hollenhorst plaques. In 1961, first cases of [[blue toe syndrome]], described as [[painful toes]], following treatment with oral [[anticoagulation]] were reported by Feder and Auerbach. But the term of [[blue toe syndrome]] was first used in 1976. The association between [[aortic plaque]] on [[TEE]] and development of [[emboli]] was reported in 1990.
==Historical Perspective==
==Historical Perspective==
The phenomenon of embolisation of cholesterol was first recognized by the Danish [[physiology|physiologist]] Dr [[Peter Ludvig Panum]].<ref>{{cite journal | author=Panum PL | title=Experimentelle Beitrage zur Lehre von der Embolie | language=German | journal=Virchows Arch Pathol Anat Physiol | year=1862 | volume=25 | pages=308–310 | doi=10.1007/BF01879803}}</ref> Further pathological evidence that eroded atheroma was the source of emboli came from American [[pathology|pathologist]] Dr Curtis M. Flory, who reported the phenomenon in 3.4% of a large series of patients with severe atherosclerosis of the [[aorta]].<ref>{{cite journal | author=Flory CM | title=Arterial occlusions produced by emboli from eroded aortic atheromatous plaques | journal=Am J Pathol | year= 1945 | volume=21 | pages=549–565}} {{PMC|1934118}}</ref><ref name=Modi/>
 
*[[Cholesterol emboli]] was first described by a Danish pathophysiologist called Peter Ludvig Panum in 1862. <ref name="Panum1862">{{cite journal|last1=Panum|first1=P. L.|title=Experimentelle Beiträge zur Lehre von der Embolie|journal=Virchows Archiv|volume=25|issue=3-4|year=1862|pages=308–338|issn=0945-6317|doi=10.1007/BF01879595}}</ref> <ref name="KronzonSaric2010">{{cite journal|last1=Kronzon|first1=Itzhak|last2=Saric|first2=Muhamed|title=Cholesterol Embolization Syndrome|journal=Circulation|volume=122|issue=6|year=2010|pages=631–641|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.109.886465}}</ref>
* In 1945, the first case series of [[Arterial Occlusions]] due to [[Emboli]] were reported from 267 autopsies in the New York Hospital by Curtis M. Flory. <ref name="pmid19970827">{{cite journal| author=Flory CM| title=Arterial Occlusions Produced by Emboli from Eroded Aortic Atheromatous Plaques. | journal=Am J Pathol | year= 1945 | volume= 21 | issue= 3 | pages= 549-65 | pmid=19970827 | doi= | pmc=1934118 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19970827  }} </ref> <ref name="KronzonSaric2010">{{cite journal|last1=Kronzon|first1=Itzhak|last2=Saric|first2=Muhamed|title=Cholesterol Embolization Syndrome|journal=Circulation|volume=122|issue=6|year=2010|pages=631–641|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.109.886465}}</ref>
*The [[cholesterol]] crystals were first identified by polarized light in 1956. <ref name="KronzonSaric2010">{{cite journal|last1=Kronzon|first1=Itzhak|last2=Saric|first2=Muhamed|title=Cholesterol Embolization Syndrome|journal=Circulation|volume=122|issue=6|year=2010|pages=631–641|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.109.886465}}</ref>
* [[atheromatous]] [[embolization]] following [[vascular]] surgery was first diagnosed by Thurlbeck and Castleman in 1957. <ref name="KronzonSaric2010">{{cite journal|last1=Kronzon|first1=Itzhak|last2=Saric|first2=Muhamed|title=Cholesterol Embolization Syndrome|journal=Circulation|volume=122|issue=6|year=2010|pages=631–641|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.109.886465}}</ref>
*The [[cholesterol emboli]] in the [[retinal]] [[arterioles]] was first described by an ophthalmologist called Dr Robert Hollenhorst in 1961, which is known as Hollenhorst plaques. <ref name="Hollenhorst1961">{{cite journal|last1=Hollenhorst|first1=Robert W.|title=Significance of Bright Plaques in the Retinal Arterioles|journal=JAMA|volume=178|issue=1|year=1961|pages=23|issn=0098-7484|doi=10.1001/jama.1961.03040400025005}}</ref>
*In 1961, first cases of [[blue toe syndrome]] described as [[painful toes]] following treatment with oral [[anticoagulation]] were reported by Feder and Auerbach. <ref name="Feder1961">{{cite journal|last1=Feder|first1=Walter|title="Purple Toes": an Uncommon Sequela of Oral Coumarin Drug Therapy|journal=Annals of Internal Medicine|volume=55|issue=6|year=1961|pages=911|issn=0003-4819|doi=10.7326/0003-4819-55-6-911}}</ref>But the term of [[blue toe syndrome]] was first used in 1976. <ref name="Karmody1976">{{cite journal|last1=Karmody|first1=Allastair M.|title="Blue Toe" Syndrome|journal=Archives of Surgery|volume=111|issue=11|year=1976|pages=1263|issn=0004-0010|doi=10.1001/archsurg.1976.01360290097015}}</ref>
*In 1990, the association between [[aortic plaque]] on [[TEE]] and development of [[emboli]] was first reported. <ref name="KronzonSaric2010">{{cite journal|last1=Kronzon|first1=Itzhak|last2=Saric|first2=Muhamed|title=Cholesterol Embolization Syndrome|journal=Circulation|volume=122|issue=6|year=2010|pages=631–641|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.109.886465}}</ref>
 
 
==References==
{{reflist|2}}
 
==See also==
* [[Embolism]]
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 04:26, 28 December 2020

Cholesterol emboli syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cholesterol emboli syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholesterol emboli syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholesterol emboli syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholesterol emboli syndrome historical perspective

CDC on Cholesterol emboli syndrome historical perspective

Cholesterol emboli syndrome historical perspective in the news

Blogs on Cholesterol emboli syndrome historical perspective

Directions to Hospitals Treating Cholesterol emboli syndrome

Risk calculators and risk factors for Cholesterol emboli syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [3]

Overview

Cholesterol emboli was first described by a Danish pathophysiologist called Peter Ludvig Panum in 1862. The first case series of Arterial Occlusions due to Emboli were reported from 267 autopsies in the New York Hospital by Curtis M. Flory in 1945. The cholesterol crystals were first identified by polarized light in 1956. atheromatous embolization following vascular surgery was first diagnosed by Thurlbeck and Castleman in 1957. The cholesterol emboli in the retinal arterioles was first described by an ophthalmologist called Dr Robert Hollenhorst in 1961, which is known as Hollenhorst plaques. In 1961, first cases of blue toe syndrome, described as painful toes, following treatment with oral anticoagulation were reported by Feder and Auerbach. But the term of blue toe syndrome was first used in 1976. The association between aortic plaque on TEE and development of emboli was reported in 1990.

Historical Perspective


References

  1. Panum, P. L. (1862). "Experimentelle Beiträge zur Lehre von der Embolie". Virchows Archiv. 25 (3–4): 308–338. doi:10.1007/BF01879595. ISSN 0945-6317.
  2. 2.0 2.1 2.2 2.3 2.4 Kronzon, Itzhak; Saric, Muhamed (2010). "Cholesterol Embolization Syndrome". Circulation. 122 (6): 631–641. doi:10.1161/CIRCULATIONAHA.109.886465. ISSN 0009-7322.
  3. Flory CM (1945). "Arterial Occlusions Produced by Emboli from Eroded Aortic Atheromatous Plaques". Am J Pathol. 21 (3): 549–65. PMC 1934118. PMID 19970827.
  4. Hollenhorst, Robert W. (1961). "Significance of Bright Plaques in the Retinal Arterioles". JAMA. 178 (1): 23. doi:10.1001/jama.1961.03040400025005. ISSN 0098-7484.
  5. Feder, Walter (1961). ""Purple Toes": an Uncommon Sequela of Oral Coumarin Drug Therapy". Annals of Internal Medicine. 55 (6): 911. doi:10.7326/0003-4819-55-6-911. ISSN 0003-4819.
  6. Karmody, Allastair M. (1976). ""Blue Toe" Syndrome". Archives of Surgery. 111 (11): 1263. doi:10.1001/archsurg.1976.01360290097015. ISSN 0004-0010.

See also

References


Template:WikiDoc Sources